Cannara Biotech Inc. (TSXV:LOVE)

Cannara Biotech Ratios and Metrics

Market cap in millions CAD. Fiscal year is September - August.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 30, 2026	Aug 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021
Market Capitalization	165	165	61	90	118	149
Market Cap Growth	116.37%	168.86%	-32.29%	-23.64%	-20.54%	112.60%
Enterprise Value	183	198	105	131	146	160
Last Close Price	1.72	1.80	0.68	1.00	1.35	1.70
PE Ratio	14.43	12.59	9.51	13.02	51.35	-
PS Ratio	1.47	1.54	0.75	1.58	3.30	8.75
PB Ratio	1.48	1.61	0.70	1.13	1.77	2.32
P/TBV Ratio	1.48	1.61	0.70	1.13	1.77	2.32
P/FCF Ratio	13.31	12.05	19.05	-	-	-
P/OCF Ratio	7.44	8.22	5.73	15.29	-	-
EV/Sales Ratio	1.63	1.84	1.28	2.29	4.07	9.40
EV/EBITDA Ratio	6.82	7.04	7.62	7.92	16.91	58.11
EV/EBIT Ratio	9.09	9.13	13.69	11.17	30.25	3041.19
EV/FCF Ratio	14.78	14.47	32.55	-	-	-
Debt / Equity Ratio	0.31	0.41	0.55	0.57	0.73	0.33
Debt / EBITDA Ratio	1.30	1.47	3.45	2.75	5.54	7.15
Debt / FCF Ratio	2.81	3.05	15.04	-	-	-
Asset Turnover	0.67	0.66	0.55	0.43	0.33	0.23
Inventory Turnover	1.37	1.32	1.41	1.14	1.40	1.39
Quick Ratio	1.01	0.83	0.73	0.70	1.75	1.63
Current Ratio	2.70	2.40	2.50	2.44	3.46	2.82
Return on Equity (ROE)	11.71%	13.75%	7.68%	9.48%	3.52%	-2.98%
Return on Assets (ROA)	7.51%	8.37%	3.23%	5.48%	2.77%	0.04%
Return on Invested Capital (ROIC)	10.73%	12.08%	6.09%	10.45%	5.36%	0.09%
Return on Capital Employed (ROCE)	14.10%	16.10%	6.00%	9.70%	4.20%	0.10%
Earnings Yield	7.17%	7.95%	10.52%	7.68%	1.95%	-1.03%
FCF Yield	7.51%	8.30%	5.25%	-4.39%	-18.20%	-22.26%
Buyback Yield / Dilution	-2.18%	-1.08%	-1.83%	-2.16%	-14.80%	-7.26%

Updated Nov 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.